Standard Contracts
CYTOCOM, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 28th, 2021 • Cleveland Biolabs Inc • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of October 30, 2020 (the “Signature Date”), with an effective date of October 31, 2020 (the “Effective Date”), is by and between Cytocom, Inc. a Delaware-corporation (the “Company”) and Taunia Markvicka (the “Executive”).
CYTOCOM, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 28th, 2021 • Cleveland Biolabs Inc • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of Aug 19, 2020 (the “Signature Date”), with an effective date of August 1, 2020 (the “Effective Date”), is by and between Cytocom, Inc. a Delaware-corporation (the “Company”) and Michael Handley (the “Executive”).
AMENDMENT No. 1 to the EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 28th, 2021 • Cleveland Biolabs Inc • Pharmaceutical preparations
This Amendment No. 1 (“Amendment”) is entered into as of September 6, 2020 (“Amendment Effective Date”) by and between CYTOCOM, INC. a Delaware corporation (“CYTOCOM”) and Michael Handley, the “Executive”. CYTOCOM and Executive are each referred to individually as a “Party” and together as the “Parties”.
AMENDMENT No. 2 to the EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 28th, 2021 • Cleveland Biolabs Inc • Pharmaceutical preparations
This Amendment No. 2 (“Amendment”) is entered into effective as of October 31, 2020 (“Amendment Effective Date”) by and between CYTOCOM, INC. a Delaware corporation (“CYTOCOM”) and Michael Handley (the “Executive”). CYTOCOM and Executive are each referred to individually as a “Party” and together as the “Parties”.
AMENDMENT NO. 1 TO THE EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 28th, 2021 • Cleveland Biolabs Inc • Pharmaceutical preparations
This Amendment No. 1 (“Amendment”) is entered into as of September 6, 2020 (“Amendment Effective Date”) by and between CYTOCOM, INC. a Delaware corporation (“CYTOCOM”) and Peter Aronstam, the “Executive”. CYTOCOM and Executive are each referred to individually as a “Party” and together as the “Parties”.
AMENDMENT No. 1 to the EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 28th, 2021 • Cleveland Biolabs Inc • Pharmaceutical preparations • Delaware
This Amendment No. 1 (“Amendment”) is entered into as of March 8, 2021 (“Amendment Effective Date”) by and between CYTOCOM INC., a Delaware corporation (“CYTOCOM”) and Taunia Markvicka, the “Executive”. CYTOCOM and Executive are each referred to individually as a “Party” and together as the “Parties”.
AMENDMENT No. 2 to the EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 28th, 2021 • Cleveland Biolabs Inc • Pharmaceutical preparations
This Amendment No. 2 (“Amendment”) is entered into as of October 31, 2020 (“Amendment Effective Date”) by and between CYTOCOM, INC. a Delaware corporation (“CYTOCOM”) and Peter Aronstam, the “Executive”. CYTOCOM and Executive are each referred to individually as a “Party” and together as the “Parties”.
